WO1999018202A3 - HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS - Google Patents

HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS Download PDF

Info

Publication number
WO1999018202A3
WO1999018202A3 PCT/JP1998/004474 JP9804474W WO9918202A3 WO 1999018202 A3 WO1999018202 A3 WO 1999018202A3 JP 9804474 W JP9804474 W JP 9804474W WO 9918202 A3 WO9918202 A3 WO 9918202A3
Authority
WO
WIPO (PCT)
Prior art keywords
proteins
cdnas
cells
utilized
transmembrane domains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP1998/004474
Other languages
French (fr)
Other versions
WO1999018202A2 (en
Inventor
Seishi Kato
Shingo Sekine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sagami Chemical Research Institute
Protegene Inc
Original Assignee
Sagami Chemical Research Institute
Protegene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sagami Chemical Research Institute, Protegene Inc filed Critical Sagami Chemical Research Institute
Priority to AU92831/98A priority Critical patent/AU9283198A/en
Priority to JP2000515000A priority patent/JP2001519153A/en
Priority to CA002308120A priority patent/CA2308120A1/en
Priority to EP98945602A priority patent/EP1021531A2/en
Publication of WO1999018202A2 publication Critical patent/WO1999018202A2/en
Publication of WO1999018202A3 publication Critical patent/WO1999018202A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention provides human proteins having transmembrane domains and cDNAs coding for these proteins as well as eucaryotic cells expressing said cDNAs. All of the proteins exist in the cell membrane, so that they are considered to be proteins controlling the proliferation and the differentiation of the cells. Accordingly, the proteins can be employed as pharmaceuticals such as carcinostatic agents relating to the control of the proliferation and the differentiation of the cells or as antigens for preparing antibodies against said proteins. The cDNAs can be utilized as probes for the gene diagnosis and gene sources for the gene therapy. Furthermore, the cDNAs can be utilized for large-scale expression of said proteins. Cells, wherein these membrane protein genes are introduced and membrane proteins are expressed in large amounts, can be utilized for detection of the corresponding ligands, screening of novel low-molecular pharmaceuticals, and so on.
PCT/JP1998/004474 1997-10-08 1998-10-05 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS Ceased WO1999018202A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU92831/98A AU9283198A (en) 1997-10-08 1998-10-05 Human proteins having transmembrane domains and cdnas encoding these prot eins
JP2000515000A JP2001519153A (en) 1998-10-05 1998-10-05 Human protein having transmembrane domain and DNA encoding the same
CA002308120A CA2308120A1 (en) 1997-10-08 1998-10-05 Human proteins having transmembrane domains and cdnas encoding these proteins
EP98945602A EP1021531A2 (en) 1997-10-08 1998-10-05 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9/276269 1997-10-08
JP27626997 1997-10-08

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US09529100 A-371-Of-International 2000-08-21
US10/616,942 Continuation US20040048339A1 (en) 1997-10-08 2003-07-11 Human proteins having transmembrane domains and cDNAs encoding these proteins

Publications (2)

Publication Number Publication Date
WO1999018202A2 WO1999018202A2 (en) 1999-04-15
WO1999018202A3 true WO1999018202A3 (en) 1999-08-05

Family

ID=17567095

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1998/004474 Ceased WO1999018202A2 (en) 1997-10-08 1998-10-05 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS

Country Status (4)

Country Link
EP (1) EP1021531A2 (en)
AU (1) AU9283198A (en)
CA (1) CA2308120A1 (en)
WO (1) WO1999018202A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1220919A2 (en) * 1999-09-29 2002-07-10 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Metastasis-associated antigen c4.4a
GB0004576D0 (en) * 2000-02-25 2000-04-19 Oxford Glycosciences Uk Ltd Proteins

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
FENG Y ET AL: "HIV-1 ENTER COFACTOR: FUNCTIONAL CDNA CLONING OF A SEVEN-TRANSMEMBRANE G PROTEIN-COUPLED RECEPTOR", SCIENCE, vol. 272, 10 May 1996 (1996-05-10), pages 872 - 877, XP002031517 *
HAJNAL A ET AL: "SUBTRACTION CLONING OF H-REV107, A GENE SPECIFICALLY EXPRESSED IN H-RAS RESISTANT FIBROBLASTS", ONCOGENE, vol. 9, February 1994 (1994-02-01), pages 479 - 490, XP002065314 *
HILLIER L ET AL: "Homo sapiens cDNA clone 3' similar to TR:G433963 P18H-REV107" EMBL Database entry HS1269935 Accession number AA478132; 23 Jun 1997 *
HILLIER L ET AL: "Homo sapiens cDNA clone 3' similar to TR:G433963 P18H-REV107" EMBL Database entry HS1291066 Accession number AA496125; 03 Jul 1997 *
HILLIER L ET AL: "Homo sapiens cDNA clone 5' similar to PIR:S42794 p18H-rev 107 protein" EMBL Database entry HS961329 Accession number W04961; 08 May 1996 *
HILLIER L ET AL: "Homo sapiens cDNA clone 5' similar to SP:S42794 P18H-REV 107 protein" EMBL Database entry HS94227 Accession number T53942; 28 Feb 1995 *
HOLLOWAY M P ET AL: "A HYDROPHOBIC DOMAIN OF CA2+-MODULATING CYCLOPHILIN LIGAND MODULATES CALCIUM INFLUX SIGNALING IN T LYMPHOCYTES", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 271, no. 15, 12 April 1996 (1996-04-12), pages 8549 - 8552, XP002058790 *
KYTE J ET AL: "A SIMPLE METHOD FOR DISPLAYING THE HYDROPATHIC CHARACTER OF A PROTEIN", JOURNAL OF MOLECULAR BIOLOGY, vol. 157, no. 1, 5 May 1982 (1982-05-05), pages 105 - 132, XP000609692 *

Also Published As

Publication number Publication date
CA2308120A1 (en) 1999-04-15
AU9283198A (en) 1999-04-27
EP1021531A2 (en) 2000-07-26
WO1999018202A2 (en) 1999-04-15

Similar Documents

Publication Publication Date Title
AU560340B2 (en) Rennin from recombinant dna
NZ323795A (en) Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides
EP1005540A4 (en) Ikk-beta proteins, nucleic acids and methods
WO2001053349A3 (en) Small cell lung cancer associated antigens and uses therefor
WO2000073801A3 (en) Breast, gastric and prostate cancer associated antigens and uses therefor
NO963371L (en) Hematopoietic protein as well as materials and methods for making it
NZ502392A (en) Interleukin-18 binding proteins (IL-18BP) their preparation and use in pharmaceuticals
AU7599500A (en) Novel gl50 molecules and uses therefor
HUP0202882A2 (en) Novel b7-4 molecules and uses therefor
EP0721342A4 (en) THE SEMAPHORIN GENFAMILY
WO2002002783A3 (en) Expression vectors
EP0804609A4 (en) NOVEL p53 RESPONSE GENES
GR3019849T3 (en) Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis
WO2021133959A3 (en) Compositions and methods for gamma delta tcr reprogramming using fusion proteins
ATE226216T1 (en) NETRIN RECEPTORS
EP0789076A3 (en) G protein coupled receptor proteins, their production and use
EP1005539A4 (en) IKK-$g(a) PROTEINS, NUCLEIC ACIDS AND METHODS
WO1994026891A3 (en) Purified mammalian flt3 ligands and agonists and antagonists thereof
WO1999018203A3 (en) HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS
NO984491L (en) SCF analog preparations and methods for their preparation
WO1999027094A3 (en) HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
ATE304549T1 (en) HUMAN NETRIN-1
WO1999018199A3 (en) cDNAs CODING FOR HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS
WO2002014369A3 (en) Human kininogen d5 domain polypeptides and their use
WO2001000874A3 (en) Cancer associated antigens and uses therefor

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP MX US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP MX US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 1998945602

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2308120

Country of ref document: CA

Ref country code: CA

Ref document number: 2308120

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1998945602

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09529100

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 1998945602

Country of ref document: EP